Boston Technology Review
SEE OTHER BRANDS

Your science and technology news from Massachusetts

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Boston Technology Review.

Governance, Not Just Security: Exclaimer Reframes Email Risk for Cybersecurity Awareness Month
Warehouse Automation Solutions Market to Reach USD 96.6 Bn by 2035 at 15.1% CAGR | Transparency Market Research
Guggenheim Securities Hires Simeon Siegel to Expand Consumer Equity Research
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare
New Toll Brothers at Storyrock Community Opens in Scottsdale, Arizona
PressReader Partners with Leading Luxury Cruise Lines Oceania Cruises® and Regent Seven Seas Cruises®
Verizon accelerates fixed wireless broadband expansion with acquisition of Starry
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
Medicare Now Reimbursing for EnteroTrack’s Esophageal String Test®, Expanding Access to Patients with Eosinophilic Esophagitis
Dragonfly Energy Announces Closing of $28.75 Million Underwritten Offering of Common Stock including Full Exercise of Underwriters’ Option to Purchase Additional Shares
The Village School Recognized Among Top Private Schools in America in 2025–2026 Niche Rankings
Anthropic Expands to India in 2026
Women in Media Spotlight: 'Third Degree Burnout – A Survivor’s Guide' Celebrates LA, Phoenix and Boston Premieres
Robots, a leap forward in mining innovation: Roberto Guzmán García
CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies
Biotechnology & Pharmaceutical Services Market Set to Surge from USD 76.51 Bn in 2024 to USD 130.56 Bn by 2034 at 5.48% CAGR
Folia Health Secures $10.5M in Funding to Transform Healthcare and Research With Patient-Reported Information
Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions